GlaxoSmithKline kick-starts first-of-its-kind late-stage antibiotic test

It won’t stuff your pockets with profits and it’s not sexy, but GlaxoSmithKline is pushing forward into a phase 3 for its antibiotic work as governments continue to sound the alarm of an antibiotic-resistant future.